GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » Gross Profit

Alkem Laboratories (NSE:ALKEM) Gross Profit : ₹73,142 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories Gross Profit?

Alkem Laboratories's gross profit for the three months ended in Dec. 2023 was ₹20,192 Mil. Alkem Laboratories's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was ₹73,142 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Alkem Laboratories's gross profit for the three months ended in Dec. 2023 was ₹20,192 Mil. Alkem Laboratories's Revenue for the three months ended in Dec. 2023 was ₹33,239 Mil. Therefore, Alkem Laboratories's Gross Margin % for the quarter that ended in Dec. 2023 was 60.75%.

Alkem Laboratories had a gross margin of 60.75% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Alkem Laboratories was 60.52%. The lowest was 52.54%. And the median was 57.88%.


Alkem Laboratories Gross Profit Historical Data

The historical data trend for Alkem Laboratories's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories Gross Profit Chart

Alkem Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41,873.50 47,386.00 51,420.70 62,287.40 64,580.30

Alkem Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,919.70 14,126.90 17,691.50 21,131.00 20,192.30

Competitive Comparison of Alkem Laboratories's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkem Laboratories's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's Gross Profit distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's Gross Profit falls into.



Alkem Laboratories Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Alkem Laboratories's Gross Profit for the fiscal year that ended in Mar. 2023 is calculated as

Gross Profit (A: Mar. 2023 )=Revenue - Cost of Goods Sold
=114403.5 - 49823.2
=64,580

Alkem Laboratories's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=33238.7 - 13046.4
=20,192

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹73,142 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Alkem Laboratories's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=20,192 / 33238.7
=60.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Alkem Laboratories  (NSE:ALKEM) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Alkem Laboratories had a gross margin of 60.75% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Alkem Laboratories Gross Profit Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkem Laboratories (NSE:ALKEM) Business Description

Traded in Other Exchanges
Address
Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines